FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAMIAcadian Asset Management Inc.

Inspect →

AAOIAPPLIED OPTOELECTRONICS, INC.

Inspect →

AAONAAON, INC.

Inspect →

AAPADVANCE AUTO PARTS INC

Inspect →

AAPGASCENTAGE PHARMA GROUP INTERNATIONAL

Inspect →

AAPIApple iSports Group, Inc.

Inspect →

AAPLApple Inc.

Inspect →

AAQLAntiaging Quantum Living Inc.

Inspect →

AARDAardvark Therapeutics, Inc.

Inspect →

AASPAgassi Sports Entertainment Corp.

Inspect →

AATAmerican Assets Trust, Inc.

Inspect →

AATCAUTOSCOPE TECHNOLOGIES CORP

Inspect →

03 / FINANCIAL CHANGES

Phio Pharmaceuticals Corp. PHIO

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-05 · Retrieved: 2026-11-09

Compared with the same period of the prior year, ending 2025-09-30.

Revenue—

USD million

No comparable prior-year value

Net income-4.16

USD million

Change year over year: -1.77

Operating cash flow-2.28

USD million

Change year over year: -0.20

Total liabilities2.70

USD million

Change year over year: +1.03

Total assets11.32

USD million

Change year over year: -0.19

Liabilities / assets: 23.8% · Change: +9.4 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-05 · Retrieved: 2026-11-09

Compared with the same period of the prior year, ending 2024-12-31.

Revenue—

USD million

No comparable prior-year value

Net income-8.70

USD million

Change year over year: -1.55

Operating cash flow-7.98

USD million

Change year over year: -0.87

Total liabilities1.34

USD million

Change year over year: +0.33

Total assets21.49

USD million

Change year over year: +15.75

Liabilities / assets: 6.2% · Change: -11.5 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
IBO ↗	2025-12-31	0.03	-36,993.8%	-5,906.3%
VERA ↗	2025-12-31	—	—	—
MRVI ↗	2025-12-31	185.74	-70.4%	-31.0%
FHTX ↗	2025-12-31	30.91	-240.3%	-278.6%
TNGX ↗	2025-12-31	62.38	-162.9%	-222.6%
DWTX ↗	2025-12-31	—	—	—

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

MAZE ↗

Maze Therapeutics, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

OPAL ↗

OPAL Fuels Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

SOUN ↗

SOUNDHOUND AI, INC.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

BETR ↗

Better Home & Finance Holding Co

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

IBO ↗

IMPACT BIOMEDICAL INC.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

HYPR ↗

Hyperfine, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

PIII ↗

P3 Health Partners Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

SOC ↗

Sable Offshore Corp.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

DNA ↗

Ginkgo Bioworks Holdings, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

BZFD ↗

BuzzFeed, Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

DSP ↗

Viant Technology Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Latest standalone quarter

ACHR ↗

Archer Aviation Inc.

Filed: 2026-11-09
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →